2023. Safety, Tolerability and Efficacy of Tirbanibulin Ointment 1% Treatment on 100 cm2 of the Face and Scalp in Patients with Actinic Keratosis: A Phase 3 Study. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s264. DOI:https://doi.org/10.25251/skin.7.supp.264.